If Sentinel node micrometastases are the question, are clinical trials the answer?

Journal of Clinical Oncology

Volumn 27, Issue 28, 2009, Pages 4640-4641

  Julian, Thomas B ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; EDITORIAL; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MICROMETASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; BREAST TUMOR; FEMALE; KAPLAN MEIER METHOD; METHODOLOGY; MULTIVARIATE ANALYSIS; NOTE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; STATISTICS;

BREAST NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; SENTINEL LYMPH NODE BIOPSY;

EID: 70350439437     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.0086     Document Type: Editorial

References (13)

1. Hansen NM, Grube B, Ye X, et al: Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol 27:4679-4684, 2009
2. International (Ludwig) Breast Cancer Study Group: Prognostic significant of occult axillary lymph node micrometastases from breast cancers. Lancet 335: 1565-1568, 1990
3. Cote RJ, Peterson HF, Chaiwun B, et al: Role of immunohistochemical detection of lymph-node metastases in management of breast cancer: International Breast Cancer Study Group. Lancet 354:896-900, 1999
4. Nasser IA, Lee AK, Bosari S, et al: Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 24:950-957, 1993
5. Cserni G: Metastases in axillary sentinel lymph nodes in breast cancer as detected by intense histopathological work up. J Clin Pathol 52:922-924, 1999
6. Chen SL, Hoehne FM, Giuliano AE: The prognostic signficiance of micrometastases in breast cancer: A SEER population-based analysis. Ann Surg Oncol 14:3378-3384, 2007
7. Colleoni M, Rotmensz N, Peruzzotti G, et al: Size of breast cancer metastases in axillary lymph nodes: Clinical relevance of minimal lymph node involvement. J Clin Oncol 23:1379-1389, 2005
8. Cox CE, Kiluk JV, Riker AI, et al: Significance of sentinel node micrometastases in human breast cancer. J Am Coll Surg 206:261-268, 2008
9. Gobardhan PD, Elias SG, Madsen EVE, et al: Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: A cohort study. Ann Oncol 20:41-48, 2009
10. Paik S, Tang G, Shak S, et al: Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24:3726-3734, 2006
11. Paik S, Shak S, Tang G, et al: Expression of the 21 genes in the recurrence score assay and tamoxifen clinical benefit in the NSABP study B-14 of node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 23:6s, 2005 (abstr 510)
12. van't Veer LJ, Dai H, van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 412:530-536, 2002
13. van de Vijver, He YD, van't Veer LJ, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009, 2002